Using genetically engineered mouse models, Philip et al. reported that IDH1R132H cooperated with PDGFA and loss of Cdkn2a, Atrx, and Pten to promote high-grade astrocytoma in vivo [31]. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).